N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints
N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints
Read moreMon, 15th Apr 2019 15:33
N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints
Read more(Sharecast News) - N4 Pharma lost more than a third of its value after the company said its potential Covid-19 vaccine delivery method did not produce a positive result at stage 3 of tests.
Read moreIN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract
Read more(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed the API and nanomedicines business unit of Ardena as its contract development and manufacturing organisation partner for the technology transfer and upscaling manufacture of 'Nuvec', it announced on Tuesday.
Read moreN4 Pharma Shares Spike 30% On Successful Covid-19 Study
Read moreIN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery
Read moreUK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work
Read more(Sharecast News) - Pharmaceutical group N4 Pharma has completed the first phase of Covid-19 proof of concept work for Nuvec, the group's novel delivery system for cancer treatments and vaccines.
Read moreN4 Pharma To File Nuvec Patent Across Europe, US, Other Major Markets
Read moreN4 Pharma Raises GBP2 Million To Fund Covid-19 Research Project
Read more(Sharecast News) - Specialist pharmaceutical company N4 Pharma has raised ?2.03m through an oversubscribed placing of 50,731,250 new ordinary shares, it announced on Wednesday, at a price of 4p each.
Read moreN4 Pharma Files Patent For Nuvec Opportunities In Viral Vector Market
Read more(Sharecast News) - Specialist pharmaceutical company N4 Pharma has filed a new UK patent application around both the ability of its 'Nuvec' delivery system ability to be used to manufacture viral vectors, and to make viral vectors more efficient in applications such as ex-vivo gene therapy treatments.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: NHS Uses Induction Healthcare's Mobile App
Read more